Key points are not available for this paper at this time.
Inducting buprenorphine from methadone has traditionally involved initial opioid withdrawal, with risk of mental state deterioration in patients with serious mental illness (SMI). Micro-dosing of buprenorphine, with small incremental doses, is a novel off-label approach to transitioning from methadone and does not require a period of methadone abstinence. Given the limited literature about buprenorphine microdosing, we aimed to evaluate the feasibility and safety of inducting buprenorphine in a series of patients on methadone with SMI.
Building similarity graph...
Analyzing shared references across papers
Loading...
Vivian C. Praeger
Matthew Frei
Dan Pham
Drug and Alcohol Review
Monash University
Eastern Health
Monash Children’s Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Praeger et al. (Wed,) studied this question.
www.synapsesocial.com/papers/68e64192b6db6435875d35b0 — DOI: https://doi.org/10.1111/dar.13885